Research ArticleExperimental Studies

No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity

MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL and PATRICK GUINAN
In Vivo November 2012, 26 (6) 937-940;

Article Information

vol. 26 no. 6 937-940
PMID 
23160675
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received June 11, 2012
  • Accepted July 13, 2012
  • Published online November 16, 2012.
Copyright & License 
Copyright © 2012 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. MARVIN RUBENSTEIN1,2,3,4⇓,
  2. COURTNEY M.P. HOLLOWELL2 and
  3. PATRICK GUINAN1,2,4,5
  1. 1Division of Cellular Biology, Hektoen Institute for Medical Research, Chicago, IL, U.S.A.
  2. 2Division of Urology, Stroger Hospital of Cook County, Chicago, IL, U.S.A.
  3. 3Department of Biochemistry, Rush University Medical Center
  4. 4Department of Urology, Rush University Medical Center
  5. 5Department of Urology, University of Illinois at Chicago, Chicago, IL, U.S.A.
  1. Correspondence to: Dr. Marvin Rubenstein, Chairman-Division of Cellular Biology, Hektoen Institute for Medical Research, 2240 West Ogden Avenue, 2'nd floor, Chicago, IL 60612, U.S.A. Tel: +1 3128644621, Fax: +1 3127686010, e-mail: DrMarv{at}Prodigy.net
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
No Compensation in VEGF Expression Follows Antisense Suppression of BCL-2 Activity
MARVIN RUBENSTEIN, COURTNEY M.P. HOLLOWELL, PATRICK GUINAN
In Vivo Nov 2012, 26 (6) 937-940;
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords